These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 26875533

  • 21. Involvement of prostaglandin E2 in the first Japanese case of pachydermoperiostosis with HPGD mutation and recalcitrant leg ulcer.
    Nakazawa S, Niizeki H, Matsuda M, Nakabayashi K, Seki A, Mori T, Tokura Y.
    J Dermatol Sci; 2015 May; 78(2):153-5. PubMed ID: 25757862
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy.
    Xu Y, Zhang Z, Yue H, Li S, Zhang Z.
    J Bone Miner Res; 2021 Aug; 36(8):1459-1468. PubMed ID: 33852188
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Eicosanoid profiling in patients with complete form of pachydermoperiostosis carrying SLCO2A1 mutations.
    Oiwa T, Ishibashi M, Okuno T, Ohba M, Endo Y, Uozumi R, Ghazawi FM, Yoshida K, Niizeki H, Yokomizo T, Nomura T, Kabashima K.
    J Dermatol; 2021 Sep; 48(9):1442-1446. PubMed ID: 34114674
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Three novel mutations in the SLCO2A1 gene in two Chinese families with primary hypertrophic osteoarthropathy.
    Cheng R, Li M, Guo Y, Yao Y, Gao C, Yao Z.
    Eur J Dermatol; 2013 Sep; 23(5):636-9. PubMed ID: 24153155
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mutations in the prostaglandin transporter SLCO2A1 cause primary hypertrophic osteoarthropathy with digital clubbing.
    Busch J, Frank V, Bachmann N, Otsuka A, Oji V, Metze D, Shah K, Danda S, Watzer B, Traupe H, Bolz HJ, Kabashima K, Bergmann C.
    J Invest Dermatol; 2012 Oct; 132(10):2473-2476. PubMed ID: 22696055
    [No Abstract] [Full Text] [Related]

  • 35. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and phenotypic comparison between two subtypes of primary hypertrophic osteoarthropathy (PHO): A single-center study.
    Hou Y, Lin Y, Qi X, Yuan L, Liao R, Pang Q, Cui L, Jiang Y, Wang O, Li M, Dong J, Xia W.
    Bone; 2018 Jan; 106():96-102. PubMed ID: 28963081
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Characteristic Facial Appearance Was the Key to Diagnosing Chronic Enteropathy Associated with SLCO2A1-associated Primary Hypertrophic Osteoarthropathy.
    Sonoda A, Wada Y, Togo K, Mizukami K, Fuyuno Y, Umeno J, Fujioka S, Fukuda K, Okamoto K, Ogawa R, Okimoto T, Murakami K.
    Intern Med; 2020 Feb 15; 59(4):491-494. PubMed ID: 31611528
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Novel SLCO2A1compound heterozygous mutation causing primary hypertrophic osteoarthropathy with Bartter-like hypokalemia in a Chinese family.
    Jiang Y, Du J, Song YW, Wang WB, Pang QQ, Li M, Wang O, Lian XL, Xing XP, Xia WB.
    J Endocrinol Invest; 2019 Oct 15; 42(10):1245-1252. PubMed ID: 31004291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.